Stratifying survival: the role of social determinants of health on AML outcomes by ELN 2022 criteria.
Saved in:
| Title: | Stratifying survival: the role of social determinants of health on AML outcomes by ELN 2022 criteria. |
|---|---|
| Authors: | Shimony S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Wang Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Cronin A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Walsh TP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Charles A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Slopen N; Department of Social and Behavioral Sciences, T.H. Chan Harvard School of Public Health, Boston, MA., Cho HL; Department of Medicine, Brigham and Women's Hospital, Boston, MA., Stahl M; Department of Medical Oncology and Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT., Bystrom RP; Department of Hematologic Malignancies and Cellular Therapy, Duke Blood Cancer Center, Durham, NC., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Abel GA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Center for Bioethics, Harvard Medical School, Boston, MA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Lindsley RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Hantel A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Center for Bioethics, Harvard Medical School, Boston, MA. |
| Source: | Blood advances [Blood Adv] 2026 Mar 24; Vol. 10 (6), pp. 1879-1882. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41538295 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Stratifying survival: the role of social determinants of health on AML outcomes by ELN 2022 criteria. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shimony+S%22">Shimony S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Cronin+A%22">Cronin A</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Walsh+TP%22">Walsh TP</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Charles+A%22">Charles A</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Slopen+N%22">Slopen N</searchLink>; Department of Social and Behavioral Sciences, T.H. Chan Harvard School of Public Health, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Cho+HL%22">Cho HL</searchLink>; Department of Medicine, Brigham and Women's Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Stahl+M%22">Stahl M</searchLink>; Department of Medical Oncology and Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT.<br /><searchLink fieldCode="AU" term="%22Bystrom+RP%22">Bystrom RP</searchLink>; Department of Hematologic Malignancies and Cellular Therapy, Duke Blood Cancer Center, Durham, NC.<br /><searchLink fieldCode="AU" term="%22Luskin+MR%22">Luskin MR</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Abel+GA%22">Abel GA</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Center for Bioethics, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22DeAngelo+DJ%22">DeAngelo DJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Stone+RM%22">Stone RM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Lindsley+RC%22">Lindsley RC</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Hantel+A%22">Hantel A</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Center for Bioethics, Harvard Medical School, Boston, MA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2026 Mar 24; Vol. 10 (6), pp. 1879-1882. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41538295 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2025018032 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1879 Titles: – TitleFull: Stratifying survival: the role of social determinants of health on AML outcomes by ELN 2022 criteria. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shimony S – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: Cronin A – PersonEntity: Name: NameFull: Walsh TP – PersonEntity: Name: NameFull: Charles A – PersonEntity: Name: NameFull: Slopen N – PersonEntity: Name: NameFull: Cho HL – PersonEntity: Name: NameFull: Stahl M – PersonEntity: Name: NameFull: Bystrom RP – PersonEntity: Name: NameFull: Luskin MR – PersonEntity: Name: NameFull: Abel GA – PersonEntity: Name: NameFull: DeAngelo DJ – PersonEntity: Name: NameFull: Stone RM – PersonEntity: Name: NameFull: Lindsley RC – PersonEntity: Name: NameFull: Hantel A IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 03 Text: 2026 Mar 24 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 10 – Type: issue Value: 6 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |